Camber Pharmaceuticals Announces Addition of Olmesartan Medoxomil Tablets, USP

Key Takeaways

Camber Pharmaceuticals introduces Olmesartan Medoxomil Tablets, USP, for hypertension treatment in adults and children aged six and older.
The tablets are available in 5 mg, 20 mg, and 40 mg strengths, packaged in bottles of 30 and 90 tablets.
This product expansion highlights Camber Pharmaceuticals' dedication to offering diverse treatment options for hypertension management.

Camber Pharmaceuticals is excited to announce the addition of Olmesartan Medoxomil Tablets, USP, to its current portfolio.

Olmesartan Medoxomil Tablets, USP are indicated for the treatment of hypertension in adults and children six years of age and older to lower blood pressure.

Olmesartan Medoxomil Tablets, USP, are available in 5 mg, 20 mg, and 40 mg strengths, packaged in bottles of 30 and 90 tablets.

To find out more information on Olmesartan Medoxomil Tablets, USP, please visit: www.camberpharma.com/olmesartan

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!